6 completed. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
Follow TASK Applied Science: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 BVL-GSK098 9mg, Ethionamide 250mg, Ethionamide 250 mg - Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) | Phase 2 | Completed | TASK Applied Science | 105 | 2022-12-06 | 2025-08-21 |
| EBA, Safety and Tolerability of Sanfetrinem Cilexetil Sanfetrinem Cilexetil, Rifampicin - Tuberculosis, Pulmonary | Phase 2 | Completed | TASK Applied Science | 54 | 2022-04-21 | 2025-02-21 |
| Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide - Tuberculosis | Phase 2 | Completed | TASK Applied Science | 22 | 2020-08-17 | 2022-01-25 |
| Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence H56:IC31, Placebo - Tuberculosis, Pulmonary | Phase 2 | Completed | International AIDS Vaccine Initiative | 831 | 2019-01-31 | 2026-02-24 |
| Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV - Pulmonary Tuberculosis | Phase 2 | Completed | TASK Applied Science | 134 | 2017-11-09 | 2023-06-09 |
| Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis Meropenem, Faropenem, Amoxycillin/clavulanic acid - Pulmonary Tuberculosis | Phase 2 | Completed | TASK Applied Science | 46 | 2014-09-01 | 2018-09-13 |
Tuberculosis, Pulmonary (4) · Tuberculosis (3) · Recurrence (1) · Reinfection (1)
Meropenem (3) · Amoxicillin-Potassium Clavulanate Combination (2) · Rifampin (2) · Ertapenem (1) · Ethionamide (1) · Isoniazid (1) · Pyrazinamide (1) · bedaquiline (1) · fropenem (1) · sanfetrinem cilexetil (1)
South Africa (6) · Tanzania (1)
Marissa Russell (1) · Prof Andreas H Diacon, MD, PhD (1) · Reinard McPherson, MBChB (1) · Veronique R De Jager, MBChB (1)